Harrow
Neepa Patel has a diverse work experience in the field of quality and compliance. Neepa started their career at Tris Pharma as a QA Specialist from March 2013 to February 2016. Neepa then joined DPT Laboratories as a Quality System Specialist from February 2016 to March 2017. Neepa then worked at Lupin Pharmaceuticals where they held multiple roles including Quality Assurance Consultant from March 2017 to September 2017, Investigative Quality Assurance Specialist from September 2017 to April 2019, and Compliance Manager from April 2019 to September 2022. Currently, Neepa is working at Harrow as a Senior Manager of External Quality and Compliance since September 2022, and they have recently been promoted to the position of Associate Director, Quality and Compliance starting from September 2023.
Neepa Patel attended Kent State University. No information regarding their degree, field of study, start year, or end year has been provided.
Previous companies
This person is not in any teams
This person is not in any offices
Harrow
2 followers
Harrow (Nasdaq: HROW) is a leading U.S. eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic prescription therapies that are accessible and affordable. Harrow owns U.S. commercial rights to ten FDA-approved ophthalmic pharmaceutical products. Harrow also owns and operates ImprimisRx, the leading U.S. ophthalmic‑focused pharmaceutical compounding business, which also serves as a mail-order pharmacy licensed to ship prescription medications in all 50 states. Harrow has non-controlling equity positions in Surface Ophthalmics, Inc. and Melt Pharmaceuticals, Inc., companies that began as subsidiaries of Harrow. Harrow also owns royalty rights in four late-stage drug candidates being developed by Surface and Melt.